Re: Neal D. Shore, Joseph Renzulli, Neil E. Fleshner, et al. Active Surveillance plus Enzalutamide Monotherapy vs Active Surveillance Alone in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial. JAMA Oncol 2022;8:1128–36

Re: Neal D. Shore, Joseph Renzulli, Neil E. Fleshner, et al. Active Surveillance plus Enzalutamide Monotherapy vs Active Surveillance Alone in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial. JAMA Oncol 2022;8:1128–36

Bibliographic Details
Main Authors: Juan Gómez Rivas, Giorgio Gandaglia, Francesco Montorsi
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:European Urology Open Science
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168322023485

Internet

http://www.sciencedirect.com/science/article/pii/S2666168322023485

Similar Items